ADA Guidelines: Screening for Diabetes and Prediabetes in Asymptomatic Adults

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 183 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Diabetes: Diagnosis, Laboratory Testing, and the Current American Diabetes Association Guidelines. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Diabetes: Diagnosis, Laboratory Testing, and the Current American Diabetes Association Guidelines (online CE course)
ADA Guidelines: Screening for Diabetes and Prediabetes in Asymptomatic Adults

The ADA has created criteria for screening for diabetes or prediabetes in asymptomatic adults. Testing should be done in all asymptomatic adults who are overweight or obese (BMI ≥ 25 or ≥ 23 in Asian Americans) and who have one or more diabetes risk factors, including:
  • Physical inactivity
  • First-degree relative with diabetes
  • High-risk race and ethnicity
  • People who were diagnosed with gestational diabetes (GDM)
  • High-density lipoprotein cholesterol (HDL-C) level <35 mg/dL and/or triglyceride level >250 mg/dL
  • Hypertension (≥ 130/80 mm Hg or on therapy)
  • A1C ≥ 5.7%, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) on previous testing
  • Conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans, polycystic ovarian syndrome)
  • Cardiovascular disease (CVD) history
  • People with HIV
Note: People who were diagnosed with GDM should have lifelong testing at least every 3 years. For all other patients, testing should begin at the age of 35 years. If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results and risk status.
4. American Diabetes Association. "Standards of Medical Care in Diabetes—2024." Clinical Diabetes, vol 47, issue 1, January 2024. https://diabetesjournals.org/care/issue/47/Supplement_1.